Novartis keeps CEO pay steady, but incoming chairman pay drops
BASEL (Reuters) - Novartis kept pay for its Chief Executive Joe Jimenez steady, after cutting it last year before a Swiss vote to force companies to accept shareholder limits on executive rewards.
Related Articles
- Exclusive: Proxy firm Egan-Jones Withdraws Recommendation on Tempur Sealy also written by Reuters
- Ford Fires CEO Mark Fields; Former Steelcase Chief Jim Hackett To Take Over also categorized in BoardNews
- Lululemon Strips Its Billionaire Founder Chip Wilson Of Board Appointment also categorized in BoardNews
- Billionaire Investor Bill Ackman Trims Stake In Chipotle, But Is Still Betting Big On Burritos With 5% Stake also categorized in BoardNews
- TaskRabbit CEO Steps Down, Making Silicon Valley’s Diversity Outlook Bleak also categorized in BoardNews
- Disney Furloughs 100,000 Workers While Top Executives Will Still Get Big Bonuses also categorized in BoardNews
- Germany's Corporate Governance Problem also categorized in BoardNews
- Coca-Cola Faces Renewed Pressure Over Executive Pay also written by Reuters
- New Walgreens CEO to Get Nearly $25 Million Signing Bonus also published in Chicago Tribune
- CEOs Are Cutting Their Own Salaries In Response To The Coronavirus also categorized in BoardNews
Login to comment.